Chelsea Therapeutics International, Ltd.

Charlotte, Oklahoma, United States chelseatherapeutics.com

Overview

Chelsea Therapeutics International, Ltd., acquired by Lundbeck, was a biopharmaceutical company focused on the development of innovative pharmaceutical products for the treatment of rare and difficult-to-treat diseases. The company's portfolio included therapies for conditions such as neurogenic orthostatic hypotension.

Therapeutic areas

NeurologyCardiovascular

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Chelsea Therapeutics International, Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

ABC Biopharmaceuticals, Inc.
United States
ABX Pharmaceuticals Inc.
USA
AkerBio Pharmaceuticals, Inc.
United States
Anova Pharmaceuticals Inc.
United States
AS Pharmaceutical Inc.
USA
Berlipril Pharmaceuticals Inc.
United States
BioInnovate Pharmaceuticals, Inc.
USA
BioResearch Incorporated
USA

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo